pnhpf3a

By Joel A. Harrison, Ph.D., M.P.H.
August 10, 2018

Introduction

Our current fragmented, dysfunctional, for-profit health care system is broken. Internationally we rank poorly in both process and outcomes; yet, we are by far the most expensive health care system in the world. Not only we do we not get a bang for our bucks; but for many of us from a moral perspective we are morally bankrupt, allowing far too many people to suffer and die unnecessarily.

The solution is a non-profit single-payer healthcare system, Medicare for All, which has been proposed federally by Senator Bernie Sanders (2016), introduced in The House of Representatives as H.R. 676 (Wikipedia. National Health Care Act), and, for instance, in California as Senate Bill 562 (California Legislative Information, 2017; California OneCare, 2017; jpmassar, 2017; Morone, 2017; Pollin, 2017). The obstacles are enormous, basically going up against right-wing market ideology and legislatures bought and paid for by our for-profit health industry and their lobbyists. Whether federally or by state, the fact that obstacles exist does NOT change the fact that our current system is broken, that we are ALL at risk (e.g., Barlett, 2004; Brill, 2013).

We Are All At Risk

I could write an entire paper just documenting numerous cases where people who thought they were well-insured, discovered all too late they weren’t. The following are just a few examples:

1. Patient negotiates fees with surgeon, anesthesiologist, hospital, assuming assistant surgeon, as customary, will be paid by surgeon. Assistant surgeon bills $117,000 for 3-hour surgery and gets it (Rosenthal, 2014).

2. A woman doubled over with pain goes to emergency department at hospital. After multiple tests discovered not appendicitis; but ovarian cyst. Insurance company refused to pay as they determined wasn’t emergency. The person was supposed to diagnose herself, ultimately stuck with $12,596 hospital bill. I guess she could have waited, if appendix burst, well, that’s her bad luck. The policy of not reimbursing emergency room visits if turn out not be an emergency is growing (Kliff, 2018; see also: Abelson, 2018; Chou, 2018).

3. Between 33 percent and 80 percent of cancer survivors exhaust their savings to finance medical expenses. Up to 34 percent borrow money from friends or family to pay for care. For those who fall into debt, the level of debt is substantial. Bankruptcy rates among cancer survivors are 260 percent higher than among similar households without cancer (Ramsay, 2016).

4. “It’s not uncommon for patients who visit an in-network hospital to learn later that they’ve been treated by out-of-network providers, resulting in thousands of dollars in charges. And while the Affordable Care Act generally caps what consumers must spend out of pocket when using providers within their plan’s network, it doesn’t protect consumers from large bills from outside providers. Those providers may be free to charge the consumer for the balance of the bill that the insurer did not pay, known as ‘balance billing’” (Bernard, 2013).

5. “A long night spent struggling with what turned out to be a whooping cough infection left the Encinitas resident so exhausted that he fell and hit his head. He was taken to a hospital emergency department by ambulance. Doctors there recommended that he stay overnight for observation, a precaution to make sure he did not have a more serious injury. After leaving on Feb. 5, everything seemed fine until he received an $18,700 bill in the mail. He learned that, although he had spent the night in a bed at Scripps Memorial Hospital La Jolla, he was never technically admitted as an inpatient. Medicare pays less for observation stays than it does for people who are admitted, and Scripps was billing him for the remainder of the costs he incurred (Sisson, 2016).”

6. And, as a final example, an outrageous one, the treatment of 9/11 First Responders. Most were police or fire department employees, covered by insurance; yet, their insurances didn’t cover much of their care. Finally, Congress passed legislation 10 years later to cover them, though only certain conditions, too little too late for many who had already died and those remaining who had suffered. These were our heroes. If anyone deserved top quality care, it was them (Wikipedia. Health effects arising from the September 11 attacks).

Above is just the tip of the iceberg. Read on.

U.S. Health Care in International Comparisons

Given the power of the health insurance industry we are basically inundated with lies about other nation’s health care systems. International studies rank the U.S. poorly on numerous measures. Not only we rank poorly on infant mortality and life-expectancy; but on chronic conditions. For instance, diabetics do better in the United Kingdom (Mainous, 2006). The list goes on (Chen, 2016; Garrett, 2018; Harrison, 2018; Institute of Medicine, 2013; OECD, 2017; Sawyer, 2017; Schneider, 2017; Tikkanen, 2017). Statistics on cancer ranking the U.S. at the top are deceptive. We do much more screening than other nations, catching cancers at earlier stages, sometimes this is beneficial; but often just involves treatments that are costly and can even lower our quality of life (Wikipedia. Lead time bias; Wikipedia. Length time bias). Pap smears detect cell dysplasias (abnormalities). Most won’t progress to cancer. Prostate cancers are often so indolent that men will die years before they would have had an effect. Early interventions may save some lives; but result in infection, pain, impotence, and incontinence. According to the National Breast Cancer Coalition:

For every 2,000 women invited for screening over a 10 year period, one will have her life prolonged and 10 healthy women, who would not have been diagnosed if they had not been screened, will be treated unnecessarily. The evidence of a mortality reduction from screening is conflicting and continues to be questioned by some advocates, scientists, policy makers and members of the public. In fact, the absolute risk of a woman dying from breast cancer is less than 1% without any screening. Looking at this another way, 995.6 out of 1,000 50-year-old women will not die of breast cancer within the next ten years. This number rises to 996 out of 1,000 with regular mammography screening (National Breast Cancer Coalition, 2013; see also: Houssami, 2017).

The evidence is mounting that for those insured in the U.S., both over-diagnosis and over-treatment are often as threatening to our health as under-treatment of those who are underinsured or uninsured (e.g., Brownlee, 2007; Welch, 2011).

However, if the monies wasted on our current system were re-directed to actual treatment, where current interventions for cancer are advantageous, they would be covered. And, as discussed below, the data from a single-payer system has the potential to be used for improving health care.

Myths About Canadian Health Care

A recent article in The Atlantic stated if we were to adopt the Canadian health care system: “5,400 fewer babies would die in infancy, and we’d save about $1.3 trillion dollars in health care spending. . . And, perhaps as a result, more than 50,000 preventable deaths would be avoided.” The article does point out slightly longer wait times for non-emergency/urgent care; but this is based partly on their lower spending. If we were to maintain our current level of spending, this could be avoided (Khazan, 2014; Cecere, 2009). As a specific example. average life-expectancy for cystic fibrosis is 10 years longer in Canada than U.S. (Stephenson, 2017). On almost every measure of health care outcomes Canada does as well or better than the U.S. (Eisenberg, 2005; GAO, 1991; OECD, 2017; Robinson, 2008; Sawyer, 2017; Schneider, 2017; Tikkanen, 2017).

Canadians Seeking Health Care in U.S.: Of course Canadians get health care in the U.S. Most are either working here, attending university, touristing, or retirees wintering in Florida to escape the harsh Canadian winters. The same can be said of Americans falling ill or suffering injuries while abroad. In fact, “The U.S. Centers for Disease Control and Prevention has estimated that about 750,000 U.S. patients travel abroad each year for medical treatment. That’s a larger proportion of the U.S. population than even the highest estimates of Canadians seeking treatment abroad” (Martin, 2017).

However, the question is how many Canadians seek health care in the U.S. while residing in Canada and the answer is very few and many of these are for highly specialized health care, which, is often paid for by the Canadian single-payer health care system (Katz, 2002; Lee, 2016; McCann, 2014). Only a few years ago, the only place to receive a heart-lung transplant was Pittsburgh. Is that proof that health care everywhere else in the U.S. was deficient? It is more cost-effective with better outcomes for highly specialized care to have centers of excellence in areas such as heart surgery, cancer care, neonatal intensive care, and others, so Canadians seeking highly specialized care can seek it in the US or elsewhere in Canada, sometimes the travel distance is much shorter to the U.S. (Hillner, 2000; Luft, 1990; Jollis, 1997).

Exaggerated Wait Times: Exaggerated estimates of wait times come from studies by the Fraser Institute, a right-wing think tank with substantial funding from the Koch brothers and US Pharmaceutical Companies (Wikipedia. Fraser Institute). The Fraser Institute studies use a highly flawed methodology (McCann, 2014). Though wait times can be longer in Canada than in the US, that is, for Americans who are highly insured, there is NO evidence they compromise health outcomes. Emergency and life-threatening conditions are cared for within appropriate time parameters and over the past decade Canada has successfully implemented programs to reduce wait times for elective procedures, and the effort continues (Canadian Institute for Health Information, 2017; Health Council of Canada, 2011; Longhurst, 2016).

Canadian Doctors Moving to U.S.:  The number of Canadian doctors moving to the U.S. is actually quite small and many return to Canada (Canadian Health Services Research Institute, 2008; Freeman, 2016). And many American doctors are moving to Canada. Reasons include dealing with insurance company bureaucracies, “In the US, thanks to insurance company loopholes and technicalities, American family physicians aren’t paid up to 30% of the time, whereas under a single-payer system, only about 2% of billings aren’t covered . . .  Even referrals are a headache since insurance companies often pay only for specific hospitals and specialists” (Glausser, 2014). In Canada, doctors don’t have to worry about whether patients can afford care and can focus on their medical needs instead of their finances (CTVNews.ca Staff, 2015; Luthra, 2017; Palmer, 2017).

Though on most measures the Canadian Health Care System is superior to ours, international rankings place Canada above the U.S.; but below several other nations (Chen, 2016; Garrett. 2018; Institute of Medicine, 2013; OECD, 2017; Sawyer, 2017; Schneider, 2017; Tikkanen, 2017). According to 2015 data, $5,782 dollars per person (10.4% OF GDP) were spent by Canada, compared to the U.S. $11,916 (16.9% of GDP) (Canadian Institute for Health Information, 2018). According to Palmer (2017):

No system is perfect but that said, the Canadian system has the framework and the organization to be able to solve what problems exist and to solve the health care problems for Canadians. That structure doesn’t exist in the US. And that’s a big problem. ‘What we have in place in the United States is a structure that is chaos. There are multiple insurance companies, multiple payers all acting under different rules that they set for themselves. Also acting under the premise that a virtually unregulated free market can effectively and efficiently [deliver] health care – and that’s just not true. Health care is just not a field in which a free market works well.’ (Palmer, 2017)

For more about the Canadian health care system and innovations that could improve it, innovations easier to carry out in a single-payer system, see Rachlis, 2005.

Funding, Cost, and Administrative Waste

According to a recent 2018 Milliman Research Report, the cost to a family of four for an average employer-sponsored preferred provider organization plan is $28,166. Since inflation has been minimal, comparing the 2016 data from the United States Census Bureau which found the median income for families with four people to be $90,746, the cost of health care, on average is greater than 30% of total income (Garrett, 2018; Girod, 2018; Institute of Medicine, 2013; OECD, 2017; Papanicolas, 2018; Schneider, 2017; Tikkanen, 2017; United States Census Bureau, 2017, Table F-8: Size of Families).

If one includes Medicare, Medicaid, VA, Military, Tricare for military families, Indian Health Service, health insurance for employees of all levels of government, and health insurance covered by contract with companies doing business with various levels of government, approximately 65% of health care in the U.S. is funded through taxes (Harrison, 2008). As a percent of GDP this equals the next most expensive health care systems which cover everyone with high quality care. Over 10% of doctor office and hospital costs involve the excess administration necessary to deal with multiple payers (Casalino, 2016; Himmelstein, 2014; Ubel, 2016) and at least 20% of health care costs go to for-profit health insurance companies, including bloated salaries, stock dividends, and administrative bureaucracies (Frakt, 2018). An average doctor devotes 15 hours per week to the excess paperwork demanded by our fragmented, dysfunctional, for-profit system, hours that could be devoted to actual patient care. Much of the equipment in hospitals and especially rural hospitals is paid for by Medicare and Medicaid (Alexander, 2018; Ross, 2018). And Medicare pays for residency training of specialists (Rampell, 2013). It is impossible that the 30% or more of health care dollars that go to excess administration and profit could deliver equal or better care than if the monies were actually directed to health care (Harrison, 2008). In fact, the current system limits our choices, delays care in many cases, forces people to choose between seeing doctors and/or buying medications or paying basic necessity bills. And Illness and medical bills contribute to a large and increasing share of US bankruptcies (Dobkin, 2018; Himmelstein, 2005; Himmelstein, 2009; Sanger-Katz, 2018). So, basically, we pay for our healthcare through our taxes and then pay again both monetarily and health-wise. As for Medicaid, one paper found that some insurance companies are reaping spectacular profits off the taxpayer-funded program in California, even when the state finds their patient care is subpar (Terhune, 2017).

Given the excess administrative costs built into our healthcare system (Frakt, 2018), by just removing these, the costs of hospital stays and other medical costs will be substantially reduced. Just one absurd example should be enough, according to Professor Uwe Reinhardt: “We have 900 billing clerks at Duke. I’m not sure we have a nurse per (each) bed, but we have a billing clerk per bed…it’s obscene (Putsch, 2008).” However, a non-profit single-payer system will actually provide a global budget for hospitals based on a careful analysis of their operations, so, the risk of hospitals closing is pure propaganda from the for-profit industry, not a valid claim.

In other nations sick and injured people and their loved ones can focus on getting better. In the US we are deluged with bills, paperwork, and fighting with insurance companies, a never ending nightmare just when we are at our most vulnerable (Rice, 2018). A non-profit single-payer system WILL NOT COST MORE THAN OUR CURRENT SYSTEM. IT WON’T INVOLVE NEW DOLLARS. People don’t understand that “benefits” included with our jobs are really part of our total compensation (Heathfield, 2018; New Mexico State Personnel Office, 2014). Whether an employer offers health insurance or not affects our salaries. In the past few years wage increases have flattened out and/or changes in health insurance, premiums and deductibles have grown. So, remove the employer from the equation and have a modest percentage of income, smaller than our share of premiums, covering our entire families, with no deductibles and copays, NO PAPERWORK. By rolling Medicare, Medicaid, and a percent tax on incomes, similar to the current taxes for Social Security (FICA) and Medicare, into one system, we could achieve universal coverage with access and choice determined by us and for the vast majority costing less than our current system. Additional sources of revenue have been proposed, such as a modest tax on financial transactions (Friedman, 2013; Friedman, 2017a; Friedman, 2017b; Sanders, 2016). Of course, given the power of the insurance lobby, Washington may refuse; but the money is there and we should fight for it.

We are the only health care system in the world designed first and foremost to make a profit, not to care for people. In the past few years, for instance in California, health care costs have increased by 240% compared with 40% for the Consumer Price Index (California Health Care Foundation, 2017; Huffman, 2017). In no way can the introduction of newer technologies come close to explaining this. In fact, one study found after adjustment for price inflation, 50% of the increase could not be explained by increases in population size, aging of the population, changes in disease prevalence or incidence, or service utilization (Dieleman, 2017).

Extortionist Level Drug Pricing

The recent scandal of raising Epipen prices to $800 is just one example. But even the original $400 for a packet of two Epipens was outrageous given they cost between an estimated $8 – $30 for a two-pack and sell in the UK for $69. In fact, the Epipen was developed for our military (Bloomberg, 2016; Mangan, 2016; Nutting, 2016; Ramsey, 2016; Seipel, 2017; White, 2016). Numerous studies have shown that claims by pharmaceutical companies of the cost of developing new drugs are grossly exaggerated (Light, 2011; Medecins Sans Frontieres, 2014; Prasad, 2017; Public Citizen, 2001; Public Citizen, 2017; Relman, 2002). In fact, over 95% of the basic research is funded by the government and even 50% of new classes of drugs (Light, 2005). The pharmaceutical industry is among the most profitable industries, only equaled by banks; but outdistancing carmakers, oil and gas, and media (Anderson, 2014).

The FDA’s patent of a drug creates a monopoly.

A monopoly exists when a specific person or enterprise is the only supplier of a particular commodity. . . Monopolies are thus characterized by a lack of economic competition to produce the good or service, a lack of viable substitute goods, and the possibility of a high monopoly price well above the seller’s marginal cost that leads to a high monopoly profit (Wikipedia. Monopoly).

The object of patents is to encourage research and innovation in order to benefit the public. The public is certainly does NOT benefited from extortionist level prices and profits. A single-payer health care system will be able to negotiate drug prices, allowing reasonable, not extortion level profits.

In 2003, Congress passed the Medicare Prescription Drug, Improvement, and Modernization Act. Billy Tauzin, as chair of the U.S. House Committee on Energy and Commerce, which oversees the drug industry, played a key role in shepherding the bill through Congress, including prohibiting the government from negotiating lower drug prices and banning the importation of identical, cheaper, drugs from Canada and elsewhere. Even with bargaining the pharmaceutical industry would have increased profits from the addition of a large number of people able to purchase drugs; but greed has no bounds. Tauzin resigned from Congress after the bill was passed and became head of the Pharmaceutical Research and Manufacturers of America at a salary estimated at $2 million per year. Does this raise any red flags (Ludwig, 2015; Wikipedia. Medicare Prescription Drug, Improvement, and Modernization Act)? The VA, Kaiser Permanente, Blue Cross, everyone else pays less for drugs than Medicare because they can negotiate. In fact, some drugs are actually cheaper if purchased directly from a local pharmacists, bypassing the profits and additional administrative costs from the Pharmacy Benefits Managers created by the bill (Ornstein, 2017). Gag orders often prohibit a pharmacist from discussing pricing with customers (Pear, 2018). By negotiating prices the Medicare donut hole could be eliminated (Congressional Budget Office, 2007a; Consumer Union, 2006; Families USA, 2007; Gaffney, 2018; Health Markets, 2018; Light, 2012; Light, 2013).

Complete Coverage, Dental, Home Health Care, Nursing Homes

A non-profit single-payer system will also include dental care, home health care, nursing homes and skilled nursing facilities. Poor painful teeth lead to poor nutrition which affects our diet which affects overall health. It affects our self-image, our ability to concentrate, our productivity, whether as students or workers, and, of course increases the need for health care (CDC, 2018). Quality home health care, allowing people to stay in their homes, is both cheaper than nursing homes and maintains a better quality of life (Ball, 2018; Gerace, 2011; NPR, 2018). With global budgets, nursing homes will have the requisite number of trained health care providers rather than employees in billing offices. Currently new hospitals are being built where each patient will get his/her own room. We could do the same for nursing homes. Just because one is infirm shouldn’t mean the loss of privacy and dignity. We could have such a system given that the monies now going to profits and bloated salaries for administrators, even for non-profit nursing homes, would go to actual care (Zimmerman, 2011).

Good For Business

A non-profit single-payer system will reduce job lock. Currently, many talented individuals are stuck in jobs that are not a good match because they need to maintain health insurance. Imagine some talented individuals wanting to start their own firm, one has a chronic health condition or ill child, the cost of health insurance for individuals or small firms would either be prohibitive or come with high deductibles and copays, not leaving monies for investing in the company, so they stay with their current company (Baker, 2015). Health insurance reduces the competitiveness of American companies in international competition, both upping the overall production costs and devoting time and energy in negotiating yearly insurance contracts for employees. Especially small businesses, the backbone of our economy and largest employer overall, are negatively affected by our current system. If one chooses to ensure its employees, the increased costs put it at a disadvantage against those who choose not to (Johnson, 2012; Leenson, 2017; Reinhardt, 1989).

Why Should Immigrants, including Undocumented, Be Covered?

For those opposed to undocumented aliens receiving health care, numerous studies have found that they contribute significantly to our economy and pay taxes. In fact, an Institute of Medicine study estimated the productivity loss to our economy due to lack of insurance at up to $130 billion in 2000 and if insured the cost of care at up to $69 billion, both would be much higher today (Institute of Medicine, 2003). The Institute of Medicine series of studies on the effects of uninsurance included immigrants, both documented and undocumented (Institute of Medicine, 2009). So, it costs our economy more to not insure everyone. If injured on the job, a job contributing to our economy, shouldn’t they receive care? More importantly, despite President Trump’s push to build a wall, it would be virtually impossible to eliminate them, so, we risk exposure to infectious diseases, e.g., in restaurants, day care centers, in elevators, etc. If not a moral obligation, then enlightened self-interest should prefer they be treated rather than remain contagious (Congressional Budget Office, 2007; Edsall, 2016; Federal Reserve Bank of Dallas, 2003). Not only immigrants use disproportionately less medical care than their representation in the U.S. population would indicate (Goldman, 2006); but they actually contribute to Medicare’s solvency (California Healthline, 2015; Flavin, 2018; Zallman, 2013).

Surveys have shown that the majority of Americans support a non-profit single-payer health care system; but only if it doesn’t include illegal immigrants (Rasmussen, 2009). U.S. law requires providing emergency care to anyone (Wikipedia. Emergency Medical Treatment & Labor Act). Unfortunately, the uninsured “receive fewer needed services, worse quality care, and have a greater risk of dying in the hospital or shortly after discharge,” even from trauma care (Institute of Medicine, 2002).  And as the number of uninsured increases, the quality of health services in a community decrease (Institute of Medicine, 2009).

Besides the fact that they have contributed to the system, besides the risks of infectious diseases, besides the immorality, besides the effects of uninsured on availability of quality care in a community, denying care to anyone lacking proof of insurance could put us all at risk in an emergency. Imagine you suffer a heart attack or an injury and have no proof of insurance. The uninsured get less follow-up care, so their risk of another emergency is high. So, besides the immorality, it isn’t rational to be against a program that will benefit us and our loved ones just to ensure that others don’t benefit as well, enlightened self-interest.

Healthcare Doesn’t Meet the Assumptions of a Market Model

Healthcare DOESN’T fit into a market-based system, regardless of how hard those who profit from it at our expense try to fit a square peg into a round hole (Arrow, 1963). Market economics require “free” access to information and, of course, the ability to evaluate it; but how many of us with cancer understand the basics of medicine, can evaluate peer-reviewed journal articles, know how to search the literature, even have the time or ability to focus when ill? And if in a car accident or suffering a heart attack, how many will be able to call around to various emergency departments to price shop? And how would one even price shop, not knowing once there what will be necessary (e.g., Mehrota, 2017)? And, as explained above, we already pay through our taxes what covers everyone in several other nations with a high level of quality care. It would take a separate article just to explain why health care doesn’t fit in market economics. And how does 65% of health care costs from tax dollars fit into a free market model? One excellent book explains the basic assumptions of a market model and why health care just doesn’t fit into it:

Thomas Rice (2015). “The Economics of Health Reconsidered,” Fourth Edition. Health Administration Press. Used copies of earlier editions are available on Amazon marketplace at reasonable prices. The basics don’t change between editions, just more up-to-date examples, and criticisms of earlier editions are dealt with.

Non-Profit Single-Payer is NOT Socialized Medicine

A non-profit single-payer system is NOT socialized medicine. It is Medicare for All. Delivery of health care will be by non-profit hospitals and clinics and private practicing physicians. Rather than choosing an insurance plan, if possible, or taking that offered by ones employer, one will be able to actually choose the hospital, clinic, and health care practitioner, without being locked into any network determined by the profit motive of health insurers. Unfortunately, all too often words like “socialism” are used to arouse emotions that stop people from further investigating a policy. Socialism DOES NOT apply to a non-profit single-payer healthcare system, though, as the saying goes: “A lie told often enough becomes the truth.” I have lived in both Sweden and Canada. Swedish healthcare is socialized medicine. Facilities, hospitals and clinics, are owned and run by the government and medical personnel are salaried, except for dentist who operate private practices. In Canada, hospitals and clinics are privately owned and physicians work in private practices. Dental and long term care are not universally covered; but some Provinces do cover them for specific groups, e.g., dental care for children and seniors and home health care and nursing homes for seniors. International studies show both systems superior to ours; but, given American culture, a non-profit single-payer system would be more acceptable.

Non-Profit Single-Payer is NOT a Ponzi Scheme

A non-profit single-payer system is NOT a Ponzi, pyramid, scheme transferring money from the young to the old and sick. A pyramid scheme is one-way, those at the top benefit and those at the bottom lose (Wikipedia. Ponzi scheme). A single-payer system is more like a revolving door, first one is outside, then inside. All of us will eventually grow old and at some time in our lives suffer injury or illness and none of us can be held responsible for our genetics, a roll of the dice. Young people do suffer injuries, cancer, and other illnesses. If they are uninsured, they still receive at least emergency care and, thus, we pay for it. As discussed above, the level of care will be less. By removing the excess administrative costs and profits, our parents, grandparents, and others are covered as we will be in turn. When I was in elementary school, my father’s taxes paid into the system as did others. Even when he was unemployed I continued with my education. When I became an adult, my taxes paid into the system so that the next generation of children would be educated and I gladly did this despite having no children of my own (Reuss, 2012).

Potential Health Services Research, Improved Care

Despite literally billions of dollars spent on medical and pharmaceutical research, problems still exist, including grandfathered interventions. Questions regarding which interventions for which conditions work still exist. Even with the absolute best clinical trials, the risk of rare but serious side-effects will not be found. Our drug laws allow any drug, once approved by the FDA for one condition, be used “off-label” by physicians for any condition. Sometimes the off-label use of a drug really does work; but often it doesn’t. We don’t know how many physicians prescribe an off-label drug for a specific condition, how many discontinued its use due to lack of efficacy or side-effects, nor even if improvements followed, if one could attribute them to the off-label drug or other factors. Circa 20% of all drug sales involve off-label use which adds to our overall cost of health care (Carr, 2017; GAO, 2008; Orac, 2012; Wikipedia. Off-label use). With a non-profit single-payer system, either one standardized database for entry of all patient demographics, conditions, and treatments or a linking system for several already existing databases, has the potential to improve healthcare by assigning teams to investigate everything from surgeries to drugs, FDA approved usage as well as off-label, and vaccines. Numerous large studies have found that the risk from vaccines is minuscule compared to benefits (CDC, 2017); but having data for literally all children could allow one to look at any rare increased risk from “pre-existing conditions” and assuage the fears of parents reluctant to vaccinate their children. Of course, strong laws and enforcement will need to be developed to protect patient confidentiality; something not well-protected with employer-based health insurance.

Conclusion

Sooner or later all of us will face injury or illness. No system is perfect and there will always be anecdotes of one or a few cases where failures occurred. Unfortunately, as with the red flag of labeling something as “socialist,” anecdotes play on our emotions and we fail to ask the question: “Compared to what?” For every anecdote about a case example of poor care in a Western technologically advanced nation offering universal health care, whether single-payer or socialist, one can find a far greater number in the U.S. A non-profit single-payer health care system ensures that we will be able to choose our doctors and hospitals, get the highest quality of care, without fighting with insurance companies, without being inundated with paperwork, and without worrying about finances. In addition, regardless of our employment, our families will be covered.

The choice is simple: Do we continue to fund through our taxes a system to enrich a few or adopt a non-profit single-payer system that numerous international studies have shown to cover everyone at a high level of care?

Joel A. Harrison, Ph.D., M.P.H., a native San Diegan, is a retired epidemiologist. Dr. Harrison has lived and studied in both Canada and Sweden. Dr. Harrison has been a long-time supporter of a non-profit single-payer health care system/Medicare for All and a strong supporter of vaccinations wherein he has, as a volunteer, been writing articles for Every Child by Two, a nonprofit founded in 1991 to promote vaccinations. You can find his articles here and here.

References

Note that I use Wikipedia in the references. I only do this if the Wikipedia article includes references that I have checked out. Thus, rather than listing even more references, this supplies a convenient shorthand.

Abelson R, Sanger-Katz, Cresell (2018 May 19). As an Insurer Resists Paying for ‘Avoidable’ E.R. Visits, Patients and Doctors Push Back: Guessing wrong on when a condition is a life-threatening medical emergency could mean a large bill. Or worse. The New York Times.

Alexander B (2018 Jan 9). America’s Rural Hospitals Are Dangerously Fragile. The Atlantic.

Allen M (2018 May 25). Why Your Health Insurer Doesn’t Care About Your Big Bills. Propublica.

Anderson R (2014 Nov 6). Pharmaceutical industry gets high on fat profits. BBC News.

Arrow KJ (1963 Dec). Uncertainty and the Welfare Economics of Medical Care. The American Economic Review; 53(5): 941-973. [Reproduced in Bulletin of the World Health Organization | February 2004, 82 (2)]

Baker D (2015 Mar). Baker (2015 Mar). Job Lock and Employer-Provided Health Insurance: Evidence from the Literature. AARP Public Policy Institute.

Ball MS (accessed 2018 May 20). Aging in Place – A Toolkit for Local Governments. Community Housing Resource Center.

Barlett DL, Steele JB (2004). Critical Condition: How Health Care in America Became Big Business & Bad Medicine. Doubleday.

Bernard TS (2013 Oct 18). Out of Network, Not by Choice, and Facing Huge Health Bills. New York Times.

Bloomberg (2016 Sep 29). Why the $600 EpiPen costs $69 in Britain. Crain’s Chicago Business.

Brill S (2013 Feb 20). Bitter Pill: Why Medical Bills Are Killing Us. Time.

Brownlee S (2007). Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer. Bloomsbury.

California Health Care Foundation (2017 Mar). California Employer Health Benefits: Prices Up, Coverage Down.

California Healthline (2015 Jun 29). Undocumented Immigrants Help Keep Medicare Solvent, According to New Study.

California Legislative Information (2017 May 26). SB-562 The Healthy California Act.

California OneCare (2017). How Could Medicare for All Work in California?

Canadian Institute for Health Information (2017 Mar). Analysis in Brief: Wait Times for Priority Procedures in Canada, 2017.

Canadian Institute for Health Information (accessed 2018 May 28). How does Canada’s health spending compare internationally?

Canadian Health Services Research Institute (2008 Mar). MYTH: Canadian doctors are leaving for the United States in droves.

Carr T (2017 Jan 4). Off-Label Use: Should Drugs Do Double Duty? Consumer Reports.

Casalino LP, Gans D, Weber R et al. (2016 Mar). US Physician Practices Spend More Than $15.4 Billion Annually To Report Quality Measures. Health Affairs; 35(3): 401-6.

CDC (2018 May 2). Oral Health.

CDC (2017 Jun 7). Vaccine Safety Publications.

Cecere (2009 Sep 17). New study finds 45,000 deaths annually linked to lack of health coverage. The Harvard Gazette.

Chen A, Oster E, Williams H (2016 May). Why Is Infant Mortality Higher in the United States Than in Europe? American Economic Journal. Economic policy; 8(2): 89-124.

Chou SC, Schuur JD (2018 Mar 9). Beware this insurer’s sneak attack on emergency care coverage. STAT.

Congressional Budget Office (2007a Jan). Prescription Drug Pricing in the Private Sector.

Congressional Budget Office (2007b Dec). The Impact of Unauthorized Immigrants on the Budgets of State and Local Governments.

Consumer Union (2006 Oct). Not Low Enough – Medicare Part D ‘Donut Hole’ Prices Compared with Retail and VA Prices.

CTVNews.org Staff (2015 Dec 27). U.S. doctor who moved to Ont. shares observations on Canadian health care.

Dieleman JL, Squires E, Bui AL et al. (2017 Nov 7). Factors Associated With Increases in US Health Care Spending, 1996-2013. JAMA; 318(17): 1668-1678.

Dobkin C, Finkelstein A, Kluender R, Notowidigdo MJ (2018). Economic Consequences of Hospital Admissions. American Economic Review; 108(2): 308-352.

Edsall TB (2016 Sep 29). What Does Immigration Actually Cost Us? The New York Times.

Eisenberg (2005 Jul 11). Outcomes and Cost of Coronary Artery Bypass Graft Surgery in the United States and Canada. Archives of Internal Medicine; 165: 1506-1513.

Families USA (2007 Jan). No Bargain: Medicare Drug Plans Deliver High Prices.

Federal Reserve Bank of Dallas (2003 Nov). U.S. Immigration and Economic Growth: Putting Policy on Hold. Issue 6.

Flavin L, Zallman L, McCormick D, Boyd JW (2018 Aug). Medical Expenditures on and by Immigrant Populations in the United States: A Systematic Review. International Journal of Health Services.

Frakt A (2018 Jul 16). Hidden From View: The Astonishingly High Administrative Costs of U.S. Health Care: The complexity of the system comes with costs that aren’t obvious but that we all pay. The New York Times.

Freeman TR, Petterson S, Finnegan S, Bazemore A (2016). Shifting tides in the emigration patterns of Canadian physicians to the United States: a cross-sectional secondary data analysis. BMC Health Services Research; 16: 678.

Friedman G (2013 Jul 31). Funding HR 676: The Expanded and Improved Medicare for All Act. How we can afford a national single-payer health plan. Physicians For A National Health Program.

Friedman G (2017 Sep 14). Funding Medicare for All. Dollars and Sense.

Friedman G (2017 Sep 28). ‘Medicare for all’ could be cheaper than you think. UMassAmherst.

GAO (1991 Jun). Canadian Health Insurance: Lessons for the United States.

GAO (2008 Jul). Prescription Drugs: FDA’s Oversight of the Promotion of Drugs for Off-Label Uses.

Gaffney A, Lexchin J (2018 May 17). Healing an ailing pharmaceutical system: prescription for reform for United States and Canada. British Medical Journal.

Garrett L (2018 Apr 24). The Royal Baby Is Lucky He Wasn’t Born in America: Everyone in the West, royalty or not, gets better maternal health care than parents in the United States. Foreign Policy.

Glauser W (2014 Aug 5). US doctors migrating north. Canadian Medical Association Journal; 186(11): E407-E408.

Gerace A (2011 Aug 21). Home Health Care 75% Cheaper than Nursing Home Care. Senior Housing News.

Girod C, Hart S, Weltz S (2018). 2018 Milliman Medical Index. Milliman Research Report.

Goldman DP, Smith JP, Sood N (2006 Nov). Immigrants And The Cost Of Medical Care. Health Affairs; 25(6); 1700-1711

Harrison JA (2008). Paying More, Getting Less. How much is the sick U.S. health care system costing you? Dollars and Sense Magazine.

Harrison JA (accessed 2018 May 20). International Resources. Physicians For A National Health Program.

Health Council of Canada (2011 May). Progress Report 2011: Health Care Renewal in Canada.

Health Markets (2018 Mar 28). What is the Medicare Donut Hole?

Heathfield SM (2018 Apr 9). What’s in a Comprehensive Employee Benefits Package? The Balance Careers.

Hillner BE, Smith TJ, Desch CE (2000 Jun). Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. Journal of Clinical Oncology; 18(11): 2327-40. ABSTRACT

Himmelstein DU, Warren E, Thorne D, Woolhandler (2005 Feb 2). Illness And Injury As Contributors to Bankruptcy. Health Affairs; Web Exclusives: W5-63-W5-73.

Himmelstein DU, Thorne D, Warren E, Woolhandler S (2009 Aug). Medical Bankruptcy in the United States, 2007: Results of a National Study. American Journal of Medicine; 122(8): 741-6.

Himmelstein DU, Jun M, Busse R er al. (2014). A Comparison of Hospital Administrative Costs in Eight Nations: US Costs Exceed All Others By Far. Health Affairs; 33(9): 1586-1594.

Houssami N (2017). Overdiagnosis of breast cancer in population screening: does it make breast screening worthless? Cancer Biology & Medicine; 14(1): 1-8.

Huffman M (2017 Apr 27). Report: consumers’ out-of-pocket medical expenses rising. ConsumerAffairs.

Institute of Medicine (2002 May). Care Without Coverage: Too Little, Too Late (Report Brief). National Academies Press.

Institute of Medicine (2003 Jun). Hidden Costs, Value Lost: Uninsurance in America (Report Brief). National Academies Press.

Institute of Medicine (2009 Feb). America’s Uninsured Crisis: Consequences for Health and Health Care. National Academies Press.

Institute of Medicine (2013 Jan). U.S. Health in International Prospective: Shorter Lives, Poorer Health. The National Academies Press.

jpmassar (2017 Jun 7). A FAQ About California’s Single Payer Health Care Legislation, SB 562. Daily Kos.

Johnson T (2012 Mar 26). Healthcare Costs and U.S. Competitiveness. Council on Foreign Relations.

Jollis JG, Peterson ED, Nelson CL et al. (1997 Jun 3). Relationship Between Physician and Hospital Coronary Angioplasty Volume and Outcome in Elderly Patients. Circulation; 95(11): 2485-91.

Katz SJ, Cardiff K, Pascali M et al. (2002 May). Phantoms In The Snow: Canadians’ Use Of Health CareServices In The United States. Health Affairs; 21(3): 19-31.

Khazan O (2014 Oct 1). What If America Had Canada’s Healthcare System? It would not be a socialist paradise. At least, not entirely. The Atlantic.

Kliff (2018 Jan 29). An ER visit, a $12,000 bill — and a health insurer that wouldn’t pay.

Lee MYH (2016 Oct 11). Fact Checker: Trump’s claim about Canadians traveling to the United States for medical care. The Washington Post.

Leenson E, Geiger D (2017 Oct 17). Why business should demand single-payer health care. San Diego Union-Tribune.

Light DW, Lexchin J (2005 Oct 22). Foreign free riders and the high cost of medicines. BMJ; 331: 958-960.

Light  DW, Warburton R (2011 Mar). Demythologizing the high costs of pharmaceutical research. BioSocieties; 6(1): 34-50.

Light DW, Lexchin JR (2012 Aug 11). PHARMACEUTICAL R&D: What do we get for all that money? BMJ; 345 (7869): 22-25.

Light DW, Kantarjian H (2013 Nov 15). Market Spiral Pricing of Cancer Drugs. Cancer; 119(22): 3900-2.

Longhurst A, Cohen M, McGregor M (2016 Apr). Reducing Surgical Wait Times: The Case for Public Innovation and Provincial Leadership. Canadian Centre for Policy Alternatives.

Ludwig M (2015 Sep 30). How Much of Big Pharma’s Massive Profits Are Used to Influence Politicians? Truthout.

Luft HS, Garnick Dw, Mark DH, McPhee SJ (1990). Hospital Volume, Physician Volume, and Patient Outcomes: Assessing the Evidence. Health Administration Press.

Luthra S (2017 Dec 14). Heading North: American Doctors Report Back From Canada. NPR.

Mainous AG, Diaz VA, Saxena S et al. (2006 Sep). Diabetes management in the USA and England: comparative analysis of national surveys. Journal of the Royal Society of Medicine; 99: 463-469.

Mangan D (2016 Aug 25). EpiPens cost just several dollars to make. Customers pay more than $600 for them. CNBC.

Martin D (2017 Sep 18). Canadian doctor to U.S.: Try single-payer health care instead of trashing it. USA Today.

McCann D (2014 Mar 17). “42,000 Canadians come to the United States for care” – Really? Physicians for a National Health Program.

Medecins Sans Frontieres (2014 Nov 18). R&D Cost Estimates: MSF Response to Tufts CSDD Study on Cost to Develop a New Drug.

Mehrota A (2017 Sep 14). I’m the perfect person to price shop for an operation. But the process went terribly. STAT.

Morone JA (2017 Dec 7). How to Think about “Medicare for All”. New England Journal of Medicine; 377: 2209-2211.

National Breast Cancer Coalition (2013). Overdiagnosis and Overtreatment.

New Mexico State Personnel Office (2014). Total Compensation.

NPR (2018). Home or Nursing Home; Special Series.

Nutting R (2016 Sep 2). Opinion: What’s wrong with price gouging for EpiPens? Nothing, and everything. MarketWatch.

OECD (The Organisation for Economic Co-operation and Development) (2017). Health at a Glance 2017: OECD Indicators.

Orac (2012 Dec 6). Big pharma wins a battle on off-label prescribing. Respectful Insolence.

Ornstein C, Thomas K (2017 Dec 9). Prescription Drugs May Cost More With Insurance Than Without It. The New York Times.

Palmer K, Petch J, Bournes D (2017 Oct 19). What it’s really like to practice medicine in the U.S. Healthy Debate.

Papanicolas I, Woskie LR, Jha A. (2018 Mar 13). Health Care Spending in the United States and Other High-Income Countries. JAMA; 319(10): 1024-1039. ABSTRACT

Pear R (2018 Feb 25). Pharmacists upset they can’t talk drug prices with patrons. The New York Times.

Physicians For A National Health Program. Homepage.

Physicians For A National Health Program. International Health Systems.

Pollin R (2017 May). Economic Analysis of the Healthy California Single-Payer Health Care Proposal (SB-562). Political Economy Research Institute.

Prasad V, Mailankody S (2017 Nov 1). Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval. JAMA Internal Medicine; 177(11): 1569-1575. ABSTRACT.

Public Citizen (2001 Jul). Rx R&D Myths: The Case Against The Drug Industry’s R&D “Scare Card”.

Public Citizen (2017). Would Lower Prescription Drug Prices Curb Drug Company Research & Development?

Rachlis M (2005). Prescription for Excellence: How Innovation Is Saving Canada’s Health Care System. Harper Perennial Canada.

Rampell C (2013 Dec 17). How Medicare Subsidizes Doctor Training. The New York Times.

Ramsey L (2016 Aug 27). The strange history of the EpiPen, the device developed by the military that turned into a billion-dollar business. Business Insider.

Ramsey SD, Shankaran (2016 Nov 20). Financial toxicity: a potentially devastating side effect of treating cancer. STAT.

Rasmussen Report (2009 Jun 12). Americans Support Universal Health Coverage, But Not If It Covers Illegal Immigrants.

Relman AS, Angell M (2002 Dec 6). America’s Other Drug Problem: How the drug industry distorts medicine and politics. The New Republic; 227(25): 27-41.

Reinhardt UE (1989 Winter). Health Care and American Competitiveness. Health Affairs; 8(4): 5-21.

Reuss A (2012 Nov). The Big Lie About the “Entitlement State”. Dollars and Sense Magazine.

Rice T (2016). The Economics of Health Reconsidered. Fourth Edition. Health Administration Press.

Rice T, Quentin W, Anell A et al. (2018). Revisiting out-of-pocket requirement: trends in spending, financial access barriers, and policy in ten high-income countries. BMC Health Services Research; 18: 371.

Robinson S (2008 Feb 5). 10 Myths About Canadian Health Care, Busted. Physicians for a National Health Program.

Rosenthal E (2014 Sep 20). After Surgery, Surprise $117,000 Medical Bill From Doctor He Didn’t Know. New York Times.

Ross C (2018 Jan 8). In states that didn’t expand Medicaid, hospital closures have spiked. STAT.

Sanders B (accessed 2018 May 18). Medicare for All: Leaving No One Behind.

Sanger-Katz (2018 Mar 21). Getting Sick Can Be Really Expensive, Even for the Insured. The New York Times.

Sawyer B, Gonazles S (2017 May 22). How does the quality of the U.S. healthcare system compare to other countries? Peterson-Kaiser Health System Tracker.

Schneider EC, Sarnak DO, Squires D et al. (2017 Jul). Mirror, Mirror 2017: International Comparison Reflects Flaws and Opportunities for Better U.S. Health Care. The Commonwealth Fund.

Seipel T (2017 Mar 17). EpiPen outrage: Silicon Valley engineers figure real cost to make lifesaving auto-injector two-pack — about $8. Mercury News.

Sisson P (2016 Sep 16). Dealing with difficult Medicare bill. San Diego Union-Tribune.

Stephenson A, Sykes J, Stanojevic S et al. (2017 Apr 18). Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States: A Population-Based Cohort Study. Annals of Internal Medicine; 166 (8): 537-546.

Terhune C, Gorman A (2017 Nov 5). Medi-Cal insurers reap big profits, even when patient care is subpar. Kaiser Health News.

Tikkanen R (2017). Multinational Comparisons of Health Systems Data, 2017. The Commonwealth Fund.

Ubel P (2016 Aug). Your Physician Can’t See You Yet — She’s Busy Filling Out Paperwork. Forbes.

United States Census Bureau (2017 Aug 10). Table F-8. Size of Family, All Races by Median and Mean Income – 1947 to 2016.

Welch HG (2011). Overdiagnosed: Making People SIck In The Pursuit Of Health. Beacon.

White MC (2016 Sep 7). It’s Jaw-Dropping How Little It Costs to Make an EpiPen. Money.

Wikipedia (accessed 2018 May 21). Emergency Medical Treatment and Labor Act.

Wikipedia (accessed 2018 May 23). Fraser Institute.

Wikipedia (accessed 2018 Jun 13). Health effects arising from the September 11 attacks.

Wikipedia (accessed 2018 May 23). Lead time bias.

Wikipedia (accessed 2018 May 23). Length time bias.

Wikipedia (accessed 2018 May 14). Medicare Prescription Drug, Improvement, and Modernization Act.

Wikipedia (accessed 2018 Jun 13). Monopoly.

Wikipedia (accessed 2018 May 22). Off-label use.

Wikipedia (accessed 2018 Jun 13). Ponzi scheme.

Wikipedia (accessed 2018 May 21). United States National Health Care Act.

Zallman L, Woolhandler S, Himmelstein D et al. (2013 Jun). Immigrants Contributed An Estimated $115.2 Billion More To The Medicare Trust Fund Than They Took Out In 2002 -09. Health Affairs; 32(6): 1-8

Zimmerman R (2011 Sep 16). Why Shared Hospital Rooms Are Becoming Obsolete. WBUR, Boston’s NPR News Station.

By Steffie Woolhandler, M.D., M.P.H., David U. Himmelstein, M.D., and Adam Gaffney, M.D.
The Nation, August 10, 2018

Last week, Charles Blahous at the Koch-funded Mercatus Center at George Mason University published a study suggesting that Bernie Sanders’s single-payer health-care plan would break the bank. But almost immediately, various observers—including Sanders himself—noted that according to Blahous’s own estimates, single payer would actually save Americans more than $2 trillion over a decade. Blahous doubled down on his argument in The Wall Street Journal, and on Tuesday, The Washington Post’s fact-checker accused Democrats of seizing “on one cherry-picked fact” in Blahous’s report to make it seem like a bargain.

The Post is wrong to call this a “cherry-picked fact”—it’s a central finding of the analysis—but it is probably right that single-payer supporters shouldn’t make too much of Blahous’s findings. After all, his analysis is riddled with errors that actually inflate the cost of single payer for taxpayers.

First, Blahous grossly underestimates the main source of savings from single payer: administrative efficiency. Health economist Austin Frakt aptly demonstrated the “bewildering complexity of health care financing in the United States” in The New York Times last month, citing evidence that billing costs primary-care doctors $100,000 apiece and consumes 25 percent of emergency-room revenues; that billing and administration accounts for one-quarter of US hospital expenditures, twice the level in single-payer nations; and that nearly one-third of all US health spending is eaten up by bureaucracy.

Overall, as two of us documented recently in the Annals of Internal Medicine, a single-payer system could cut administration by $500 billion annually, and redirect that money to care. Blahous, in contrasts, credits single payer with a measly fraction of that—or $70 billion—in administrative savings.

Our profit-driven multi-payer system is the source for this outlandish administrative sprawl. Doctors and hospitals have to negotiate contracts and fight over bills with hundreds of insurance plans with differing payments rates, rules, and requirements. Simplifying the payment system would free up far more money than Blahous estimates to expand and improve coverage.

Next, Blahous lowballs the potential for savings on prescription drugs. He assumes that a single-payer system couldn’t use its negotiating clout to push down drug prices, ignoring the fact that European nations and the US Veterans Affairs system achieve roughly 50 percent discounts relative to the US private sector. (Single payer’s only drug savings, he argues, will come from shifting 15 percent of brand-name prescriptions to generics.) Hence Blahous foresees only $61 billion in drug savings in 2022, even though tough price negotiations would likely achieve threefold higher savings.

Third, Blahous underestimates how much the government is already spending on health care. For instance, he omits the $724 billion that federal agencies are expected to pay for employees’ health benefits over the 10 years covered by his analysis, which would simply be redirected to Medicare for All. He also leaves out the massive savings to state and local governments, which would save nearly $3.6 trillion on employee benefits and another $5.3 trillion on Medicaid and other health programs. Hence, much of the “new money” needed to fund Sanders’s reform is already being collected as taxes.

Yes, there will need to be some new taxes—albeit much less than Blahous estimates. But those new taxes would just replace—not add to—current spending on premiums, co-pays, and deductibles. Additionally, at least some of the new taxes would be virtually invisible. For instance, the $10 trillion that employers would otherwise pay for premiums could instead be collected as payroll taxes. Similarly, Medicare for All would relieve households of the $7.7 trillion they’d pay for premiums and $6.3 trillion in out-of-pocket costs under the current system.

It’s easy to get lost in the weeds here. But at the end of the day, even according to Blahous’s errant projections, Medicare for All would save the average American about $6,000 over a decade. Single payer, in other words, shifts how we pay for health care, but it doesn’t actually increase overall costs—even while providing first-dollar comprehensive coverage to everyone in the nation. The Post’s fact-checker is wrong: Single-payer supporters can and should trumpet this important fact.

Of course, the most important benefits of single payer are altogether invisible in economic analyses like the one performed by Blahous. No matter what injury or illness we faced, we would be forever freed from one great worry: the cost of our care. It’s hard to put a price tag on that kind of freedom. Yet, paradoxically, even the slanted analysis of a libertarian economist provides evidence that it would be fiscally responsible.

Steffie Woolhandler is a Distinguished Professor of Public Health at the City University of New York at Hunter College.

David U. Himmelstein is a Distinguished Professor of Public Health at the City University of New York at Hunter College.

Adam Gaffney is a pulmonary and critical care specialist at the Cambridge Health Alliance and Harvard Medical School, and President-elect of Physicians for a National Health Program.

https://www.thenation.com…

By Dylan Scott
Vox, August 10, 2018

The muscle of the health industry lobby — pharma, health plans, doctors, and hospitals — is gathering to stop single payer.

The Hill’s Peter Sullivan had the report on Friday morning. The industry’s influence can’t be underestimated: It stopped Clintoncare. And, for better or worse, it was a boon for passing Obamacare that the industry mostly supported the legislation.

The industry’s disparate interests fight over a lot of issues, but Medicare-for-all unites them. That is going to be a factor if we get to 2021 with a Democratic Congress and president, and they decide to pursue single-payer health care.

That moment really might come. A sign times are changing: A Republican health care lobbyist called me recently to ask whether all-payer rate setting would be a better alternative to single payer, by causing less disruption. (I quibbled that you would need some kind of coverage component, given the moral urgency that is animating the left on health care.)

Still, a Republican almost endorsing price controls. That is a pretty strong indicator of where our health care debate seems to be heading.

Payment cuts for health care providers, if we eliminate private insurance and move everybody to Medicare rates, are going to come up a lot in this debate.

Those cuts are an easy thing for industry lobbyists to target and for Republicans to run ads on. Cuts could be overstated, depending on how much legitimate waste single payer can actually eliminate by consolidating the administration of health care, but the projections for Medicare for All plans are going to anticipate big cuts.

That explains the industry’s lobbying position. But reality on the ground is more complicated than that. There are absolutely health care providers who support single payer. Quite a few of them sent me emails after I asked for their thoughts last week.

Here are some of the most interesting responses. From a registered Republican working at a next-gen gene sequencing company:

Medicare is, without question, the most reliable, most predictable payer that we deal with. And for somebody like me it would be a dream to only have to deal with them. Yes, they are pretty heavily regulated. And yes, they have pretty strict guidelines for who to cover. But unlike other payers, who make life virtually impossible for smaller providers because they’re in the for-profit game (the not paying for care game), Medicare at least adheres to a clear set of rules. Other payers put up an endless set of traps against reimbursement, contracting, and other parts of the revenue life cycle that add substantial cost to services and thus increase cost to the consumer. I can say with near certainty that parties in my industry would provide services at a materially lower price and with more predictable out of pocket costs if every payer was as reliable and consistent as Medicare.

As such, I’m now, despite growing up a conservative afraid of such government largesse as “Medicare for all,” convinced that a single public payer, either as rate setter or as a true single payer, is needed. In contrast, I remain a staunch defender of private medical care, where companies such as my own and our competition do battle to increase quality and lower patient cost.

So I guess you could count me as pro-Medicare for all, a sentence I never thought I’d write 15 years ago.

From a retired neurosurgeon, who had also thought of himself as a Republican:

I practiced neurosurgery in Texas and retired 20 years ago. I started out as a pretty solid, but non-thinking, Republican, opposing perceived intrusions of Medicare into my practice. I read Himmelstein and Woolhandler’s NEJM articles and thought they were Harvard hippie Communists. Over time, I came to see that they were right, that we really need a universal health care system, as so many of my patients weren’t getting needed care. I was a bit embarrassed making as much money as I did, and would have done it for half of that.

From a radiation oncologist of more than 20 years, in Chicago and for the military:

I left full-time medicine a few years ago after getting fed up with continuously fighting insurance companies for pre-authorization and for the right to practice medicine the way I was trained within the standard published guidelines. I now work part-time seeing primarily uninsured and Medicaid patients.

A 2011 Health Affairs study found that the average US physician spends nearly $83,000 a year interacting with insurance plans. And a 2010 American Medical Association Study found the average doctor spent 20 hours a week on pre-authorization activities. This has only gotten more expensive and much worse. Under a single payer plan, this would be much easier and far less expensive.

In addition, we know that the major cost of malpractice coverage is for the continued medical care of the patient that was harmed. A single payer system would insure that any such patient would be covered for the rest of their lives and as a result, malpractice coverage would also be dramatically lower.

While reimbursement under a single payer plan most likely would be less, so would the headaches and administrative hassles and costs. And I would be able to see far more patients instead of being on the phone fighting with a case manager, while my office and malpractice coverage costs would be far less.

From a Texas oncologist still early in their career:

My general view of Medicare-for-all is that it would moderately contribute to remedying our health care spending problem, but by no means fix it.

My understanding is that the biggest savings would come from getting rid of the huge administrative dead weight in our private insurance system. However, that in and of itself would not fix the fact that billing rates are through the roof here in the US. Saving a few percent on overhead would be great, but MRIs and appendectomies are still going to cost 2x-4x here than in other OECD countries.

I am definitely heterodox among physicians in believing that our salaries (mainly among specialists such as myself) ought to be significantly lower. The greater bargaining power that a single, government payer might have could potentially rein in some of that.

On the other side, from an anesthesiologist intern in Chicago, fiscally liberal but socially conservative, who has some concerns about how single payer would handle Catholic hospitals:

The one part of a more single-payer system that worries me relates to the socially conservative opinions I have. I’m sure you have seen the series FiveThirtyEight has had the past week on the effects of Catholic hospitals coming to predominate more rural areas and even some cities. (As someone who grew up in a small town, I can say the main health care provider in the area is a Catholic hospital.) I don’t fear a single-payer system would result in individual providers being required to provide services they individually oppose for religious beliefs.

However, I do worry about whether or not there would be requirements for Catholic hospitals to provide services contrary to Catholic teaching, generally surrounding abortion or end of life care, in order to be eligible for billing Medicare. I do presume a Medicare-for-All system would pass on a party-line vote with only Democrat support and could see them trying to expand abortion coverage–either directly in a law or through regulation like many abortion coverage issues have been changed–at the same time since that issue has also grown much more partisan in the past decade.

https://www.vox.com…